Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
diagnosed with MOGAD; This is a spontaneous report received from a Consumer or other non HCP. A 38-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 28Feb2025 as dose 1, single (Batch/Lot number: unknown) at the age of 37 years, in arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 28Feb2025 as dose number unknown, single) for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; Unknown manufacturer), for Covid-19 immunization. The following information was reported: MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE (prolonged hospitalization, disability) with onset 07Apr2025, outcome "not recovered", described as "diagnosed with MOGAD". The patient prolonged hospitalization for myelin oligodendrocyte glycoprotein antibody-associated disease (hospitalization duration: 10 day(s)). The patient underwent the following laboratory tests and procedures: Visual acuity tests: (13Apr2025) like 85, notes: His vision was much better. Therapeutic measures were taken as a result of myelin oligodendrocyte glycoprotein antibody-associated disease. The clinical course was reported as follows: The patient was diagnosed with Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The exact cause was not fully understood but the neurologist thought it may have been triggered by the flu vaccine and covid booster. As a symptom of MOGAD, the patient had optic neuritis which was inflammation in the optic nerve and it was causing some vision loss, eye pain, and headache. He lost vision in his left eye (his right eye was not great either) and had headaches and eye pain. He got seven rounds of steroids (last one on 02Apr2025) to help reduce the inflammation and it was really helping. He started having headaches and eye pain again this week and he lost vision in his right eye fully on 09Apr2025. He went to get steroids on 12Apr2025 to help with inflammation. His vision was much better at like 85% on 13Apr2025. Still in hospital and receiving steroids, rounds of plasmapheresis and inebilizumab-cdon. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: healthy young adult male
Test Date: 20250413; Test Name: vision; Result Unstructured Data: Test Result:like 85 %; Comments: His vision was much better